|?|| (A;A) (A;G) (G;G) ||28|
] Association of SNAP-25, SLC6A2, and LPHN3 With OROS Methylphenidate Treatment Response in Attention-Deficit/Hyperactivity Disorder
[PMID 25989180] LPHN3 and Attention-Deficit/Hyperactivity Disorder: a susceptibility and pharmacogenetics study
[?dopt=Abstract PMID 20157310 ] A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication
[PMID 21040458] Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study.